pc:auren

Aurenar

Medical Devices

Aurenar develops a first-in-class, non-invasive, single-use neuromodulation platform designed to reduce life-threatening complications in intensive care unit patients. Its technology focuses on improving outcomes for stroke and other acute neurological conditions in ICU settings by providing scalable, bedside neuromodulation therapy.

Leadership & Board

Currently, no data available

Latest Estimated Valuation

Estimated Valuation―

Estimated Valuation―

Total Amount Raised$6M

Total Amount Raised$6M

Total Funding Rounds1

Total Funding Rounds1

Latest Funding Amount$6M

Latest Funding Amount$6M

Latest Funding RoundSeed Round

Latest Funding RoundSeed Round

Post-Money Valuation―

Post-Money Valuation―

Funding Round

Jul 28, 2026

Seed Round

$5.70M

―

Investors

Go Red for Women Venture Fund

Seed Round

Solas BioVentures

Seed Round

Seed Round

Kaleida Capital

Seed Round

Similar Companies

A snapshot of private companies similar to Aurenar, helping you discover and navigate related company profiles.

PC:LYFEG

PC:EXEXX

PC:GENRA

PC:KNEUH

Related News and Analysis

Aurenar – Weekly Recap

Aurenar – Weekly Recap

Aurenar is a neuromodulation company focused on improving outcomes for intensive care stroke patients, and this weekly summary...

2M ago

Aurenar Wins FDA Breakthrough Status for ICU Neuromodulation Device V-Link

Aurenar Wins FDA Breakthrough Status for ICU Neuromodulation Device V-Link

New updates have been reported about Aurenar. Aurenar has secured U.S. Food and Drug Administration Breakthrough Device Designation...

2M ago

Aurenar Secures $5.7M Seed Round to Advance Breakthrough ICU Stroke Neuromodulation Platform

Aurenar Secures $5.7M Seed Round to Advance Breakthrough ICU Stroke Neuromodulation Platform

New updates have been reported about Aurenar. Aurenar has closed an oversubscribed $5.7 million seed financing round to...

2M ago

equipifi’s BNPL Platform Wins FinovateFall Best of Show, Underscoring Strategic Momentum for Bank-Issued Installment Payments

equipifi’s BNPL Platform Wins FinovateFall Best of Show, Underscoring Strategic Momentum for Bank-Issued Installment Payments

New updates have been reported about equipifi. equipifi has strengthened its position in bank-centric Buy Now, Pay Later...

2h ago

Collibra Warns of ‘Hallucination Tax’ as Enterprises Struggle to Scale AI Agents

Collibra Warns of ‘Hallucination Tax’ as Enterprises Struggle to Scale AI Agents

New updates have been reported about Collibra. Collibra is positioning itself at the center of enterprise AI governance...

2h ago

Nextworld named Accelerator in Nucleus LCAP report for AI-native ERP extension platform

Nextworld named Accelerator in Nucleus LCAP report for AI-native ERP extension platform

New updates have been reported about Nextworld. Nextworld has been designated an Accelerator in Nucleus Research’s 2026 Low-Code...

2h ago

LawZero Secures Up to CAD $300 Million From Canada and Germany to Scale Safe-by-Design AI

LawZero Secures Up to CAD $300 Million From Canada and Germany to Scale Safe-by-Design AI

New updates have been reported about LawZero. LawZero has received a joint funding commitment of up to CAD...

3h ago

Corgi Insurance Broadens Property Coverage as Market Tightens

Corgi Insurance Broadens Property Coverage as Market Tightens

New updates have been reported about Corgi. Corgi Insurance is expanding its AI-driven commercial insurance portfolio to target...

4h ago

Endra Launches Agentic Power Studio and Acquires Planlabs to Build Full-Stack AI MEP Platform

Endra Launches Agentic Power Studio and Acquires Planlabs to Build Full-Stack AI MEP Platform

New updates have been reported about Endra. Endra is accelerating its push to become a full-stack AI platform...

4h ago

Ferry Health Emerges From Stealth With $9M to Automate Patient Care Navigation

Ferry Health Emerges From Stealth With $9M to Automate Patient Care Navigation

New updates have been reported about Ferry Health. Ferry Health has formally launched from stealth with an AI-driven...

6h ago